Drug firms call on FDA to add to guidance on trial enrichment

03/25/2013 | OutSourcing-Pharma.com

Large drug firms including Merck & Co., Eli Lilly and Co. and Pfizer urged the FDA to bolster its draft guidance on enrichment measures for clinical trials with additional examples involving various therapeutic areas. Pharmaceutical companies also called for increased guidance involving diagnostics.

View Full Article in:

OutSourcing-Pharma.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA